3 Things You Should Know About Targeted Therapies for Gliomas.
| Publicado en: | Oncology (08909091) Vol. 40; no. 5; pp. 228 - 232 |
|---|---|
| Autores principales: | , , |
| Formato: | CEU exam questions tables/charts Journal Article |
| Publicado: |
MJH Life Sciences
Jun2026
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=195654671&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 195654671 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 08909091 YYT jtl: Oncology (08909091) issn: 08909091 maglogo: N pubinfo: dt: Jun2026 vid: 40 iid: 5 pid: 54670 pub: MJH Life Sciences place: Cranbury, New Jersey artinfo: ui: 195654671 195654671 195654671 195654671 ppf: 228 ppct: 4 formats: fmt: @attributes: type: P tig: atl: 3 Things You Should Know About Targeted Therapies for Gliomas. aug: au: Puduvalli, Vinay K. Ahluwalia, Manmeet Margol, Ashley S. affil: Professor and Chair, Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX sug: subj: Education, Medical, Continuing Glioma Drug Therapy Education, Continuing (Credit) Cancer Patients Glioma Classification Glioma Diagnosis Immunotherapy Mitogen-Activated Protein Kinases Drug Effects Signal Transduction Drug Effects Neoplasm Grading Childhood Neoplasms Central Nervous System Neoplasms Antineoplastic Agents, Combined Therapeutic Use Antineoplastic Agents Therapeutic Use Mutation Drug Approval pubtype: Academic Journal doctype: CEU exam questions tables/charts Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|